Background: Management of Chronic Heart Failure (CHF) is quite challenging, and its prognosis remains poor. Thus, alternative and conventional treatment approaches with lifestyle modifications are needed to enhance the quality of life. One such approach is heart failure reversal treatment (HFRT) that includes Snehana (massage), Swedana (fomentation therapy), Basti (per rectal drug administration), and Hridaydhara.
Objective: The present study evaluated the effect of HFRT in CHF patients with heart failure with reduced ejection fraction (HFrEF), and relate the clinical benefit and change in hemodynamic parameters intending to improve the quality of life.
Methods: This study evaluated data from known CHF patients who visited the Madhavbaug Hospital between May 2021 to October 2021. Patients of either gender with NYHA Class I, II, III and LVEF<40 who completed 7-day (12 sessions, one each at day 1 and 7 and remaining days 2 sessions/day) HFRT therapy were included in the study. Data on blood pressure, abdominal girth (ABG) and cardiac parameters [End diastolic volume (EDV), Ejection factor (EF), Systemic vascular resistance (SVR), 6-min walk test (6 MW T), etc. was analysed pre and post-HFRT.
Results: 85 CHF patients with a mean age of 57 years and 67 (78.8%) males were enrolled in the study. The calculated EF, 6 MW T, stroke volume, and SVR significantly changed (p < 0.05) on Day 7 post-HFRT intervention. Though, BMI, ABG, EDV, SV and CO showed a positive change, it was not statistically significant.
Conclusion: HFRT demonstrated a significant change in the hemodynamics, which was also impacted positively by the improvement in 6 MW T, thereby enhancing the quality of life.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaim.2024.101083 | DOI Listing |
ESC Heart Fail
March 2025
Institute of Health Informatics Research, University College London, London, UK.
Aims: Atrial fibrillation (AF) is a frequent comorbidity in heart failure (HF). We analysed factors associated with new-onset atrial fibrillation in patients with heart failure using linked real-world UK data from primary and secondary care, along with findings from genome-wide association studies.
Methods And Results: Among 163 174 participants with a diagnosis of HF (January 1998 to May 2016) from Clinical Practice Research Datalink (CPRD) and Hospital Episodes Statistics (HES), 111 595 participants had no previous history of AF (mean age 76.
JACC Cardiovasc Interv
March 2025
Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.
A global treatment algorithm was developed for the endovascular revascularization of femoropopliteal lesions and chronic total occlusions, aiming toward a more standardized approach to endovascular treatment in patients with peripheral artery disease. The following steps are proposed. 1) Evaluation of lesion morphology based on preprocedural imaging by Duplex sonography and intravenous ultrasound for selection of lesion preparation tools.
View Article and Find Full Text PDFChest
March 2025
University of Sousse, Faculty of Medicine of Sousse, Farhat HACHED Hospital, Heart Failure (LR12SP09) Research Laboratory, Sousse, Tunisia. Electronic address:
J Am Coll Cardiol
March 2025
University of Mississippi, Jackson, Mississippi, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!